Trial · NCT02544152
Results by group96
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 96
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants Classified as an Overall Responder for Abdominal Pain | Placebo | 10 | Participants | ||
| Number of Participants Classified as an Overall Responder for Abdominal Pain | Lubiprostone | 11 | Participants | ||
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Placebo | Week 1 | 7 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Lubiprostone | Week 1 | 7 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Placebo | Week 2 | 13 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Lubiprostone | Week 2 | 8 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Placebo | Week 3 | 11 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Lubiprostone | Week 3 | 12 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Placebo | Week 4 | 13 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Lubiprostone | Week 4 | 19 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Placebo | Week 5 | 15 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Lubiprostone | Week 5 | 18 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Placebo | Week 6 | 16 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Lubiprostone | Week 6 | 15 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Placebo | Week 7 | 14 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Lubiprostone | Week 7 | 14 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Placebo | Week 8 | 11 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Lubiprostone | Week 8 | 18 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Placebo | Week 9 | 13 | Participants | |
| Number of Participants Classified as a Weekly Responder for Abdominal Pain | Lubiprostone | Week 9 | 15 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02544152/results